T2 Biosystems to Participate in the Canaccord Genuity 41st Annual Growth Conference
LEXINGTON, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,…
Pharmaceuticals, Biotechnology and Life Sciences
LEXINGTON, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,…
Las Vegas, NV, Aug. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Sky Century Investment, Inc. (OTC Markets: SKYI), a…
Announced positive results of the Saturn-1 pivotal trial evaluating TP-03 for the treatment of Demodex blepharitis; results presented at the…
Special shareholder meeting to approve, among other items, the proposed business combination with Humacyte, Inc. to be held August 24,…
ROCKVILLE, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company…
BOSTON, Aug. 04, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development…
HIGH POINT, N.C., Aug. 04, 2021 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the second…
SAN CARLOS, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on…
Company to host conference call today, August 4, at 4:30pm ET BOCA RATON, Fla., Aug. 04, 2021 (GLOBE NEWSWIRE) —…
OTO-313 Phase 2 trial in tinnitus ongoing with results expected in mid-2022OTO-413 Phase 1/2 trial expansion in hearing loss ongoing…